Dimerization of LTβR by LTα1β2is necessary and sufficient for signal transduction
Open Access
- 18 November 2013
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (49) , 19896-19901
Abstract
Significance: Cytokines are proteins that modulate the activity of target cells via activation of cell-surface receptors. The trimeric cytokines of the tumor necrosis factor superfamily typically signal by inducing homotrimerization of their cognate receptors. We use structural and biophysical approaches to show that the unique heterotrimeric tumor necrosis factor superfamily member Lymphotoxin (LT)α1β2induces dimerization rather than trimerization of the LTβ Receptor (LTβR). Cellular signaling assays were used to show that dimerization of LTβR is sufficient to activate intracellular signaling processes. Furthermore, disruption of receptor interactions at either site prevents signaling via LTβR, challenging the existing paradigm that trimeric complexes are required for signal transduction by the TNF family cytokines.Keywords
This publication has 37 references indexed in Scilit:
- Higher-Order Assemblies in a New Paradigm of Signal TransductionCell, 2013
- A role for Th17 cells in the regulation of tertiary lymphoid folliclesEuropean Journal of Immunology, 2012
- In Vivo Depletion of Lymphotoxin-Alpha Expressing Lymphocytes Inhibits Xenogeneic Graft-versus-Host-DiseasePLOS ONE, 2012
- Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor ActivationJournal of Biological Chemistry, 2011
- Decoy Strategies: The Structure of TL1A:DcR3 ComplexStructure, 2011
- Structure-based development of a receptor activator of nuclear factor-κB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosisProceedings of the National Academy of Sciences, 2010
- The Fas–FADD death domain complex structure reveals the basis of DISC assembly and disease mutationsNature Structural & Molecular Biology, 2010
- Inhibition of the lymphotoxin pathway as a therapy for autoimmune diseaseImmunological Reviews, 2008
- Preparation and Characterization of Soluble Recombinant Heterotrimeric Complexes of Human Lymphotoxins andJournal of Biological Chemistry, 1996
- Aspartic acid 50 and tyrosine 108 are essential for receptor binding and cytotoxic activity of tumour necrosis factor beta (lymphotoxin)Protein Engineering, Design and Selection, 1991